valerates has been researched along with Muscular Atrophy in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 14 (60.87) | 24.3611 |
| 2020's | 7 (30.43) | 2.80 |
| Authors | Studies |
|---|---|
| Absalón-Aguilar, A; Cervantes-Díaz, R; Gómez-Martín, D; Hernández-Gilsoul, T; Juárez-Vega, G; Kleinberg-Bid, A; Llorente, L; Maravillas-Montero, JL; Mejía-Domínguez, NR; Meza-Sánchez, D; Nuñez-Aguirre, M; Páez-Franco, JC; Pérez-Fragoso, A; Ponce-de-León, A; Romero-Ramírez, S; Sosa-Hernández, VA; Torres-Ruiz, J | 1 |
| Bear, DE; Rooyackers, O | 1 |
| Ali Abdelhamid, Y; Beach, L; Deane, AM; Fetterplace, K; Karahalios, A; Koopman, R; Presneill, JJ; Read, D; Wittholz, K | 1 |
| Branca, JJV; Di Cesare Mannelli, L; Ghelardini, C; Lucarini, E; Micheli, L; Pacini, A; Parisio, C; Tenci, B; Toti, A; Zanardelli, M | 1 |
| Breen, L; Marshall, RN; Morgan, PT; Smeuninx, B | 1 |
| Bagnoud, G; Becce, F; Berger, MM; Deutz, NEP; Engelen, MPKJ; Pantet, O; Schmidt, S; Ten Have, GAM; Thaden, JJ; Viana, MV; Voidey, A | 1 |
| Fortuna, R; Fuller, JC; Herzog, W; Sawatsky, A | 1 |
| Holeček, M | 1 |
| Cruz-Jentoft, AJ | 1 |
| Akishita, M; Eto, M; Iijima, K; Ogawa, S; Ota, H; Ouchi, Y; Yakabe, M | 1 |
| Deng, J; Duan, Y; Kong, X; Li, F; Song, B; Yan, Z; Yin, Y; Zheng, C; Zhong, Y | 1 |
| Fukuda, DH; Hoffman, JR; Kendall, KL; Moon, JR; Mustad, VA; Oliver, JS; Smith-Ryan, AE; Stout, JR; Wilson, JM | 1 |
| Agarwala, R; Drover, JW; Fitschen, PJ; Jeejeebhoy, K; Mourtzakis, M; Rahman, A; Wilund, K | 1 |
| Cheng, XW; Hu, L; Inoue, A; Kimura, K; Koike, T; Kuzuya, M | 1 |
| Brett, SJ; Frost, G; Hickson, M; Wandrag, L | 1 |
| Choi, YJ; Chung, HY; Chung, KW; Jang, EJ; Kim, MK; Kim, ND; Noh, KK; Park, CH; Park, MH; Yoon, C | 1 |
| Cabrera, E; Campos, N; Edens, NK; Girón, MD; López-Pedrosa, JM; Manzano, M; Rueda, R; Salto, R; Shreeram, S; Vílchez, JD | 1 |
| Eley, HL; Russell, ST; Tisdale, MJ | 2 |
| Aversa, Z; Baccino, FM; Bonetto, A; Costelli, P; Lucia, S; Minero, VG; Muscaritoli, M; Penna, F; Rossi Fanelli, F | 1 |
| Alway, SE; Edens, N; Hao, Y; Jackson, JR; Pereira, SL; Wang, Y | 1 |
| Alamdari, N; Aversa, Z; Castillero, E; Hasselgren, PO; Muscaritoli, M; Rossi Fanelli, F | 1 |
| Fitschen, PJ; Wilson, GJ; Wilson, JM; Wilund, KR | 1 |
7 review(s) available for valerates and Muscular Atrophy
| Article | Year |
|---|---|
HMB and leucine supplementation during critical illness and recovery.
Topics: Critical Illness; Dietary Supplements; Humans; Leucine; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Valerates | 2022 |
Nutritional Strategies to Offset Disuse-Induced Skeletal Muscle Atrophy and Anabolic Resistance in Older Adults: From Whole-Foods to Isolated Ingredients.
Topics: Aged; Aging; Creatine; Diet, High-Protein; Dietary Proteins; Dietary Supplements; Exercise; Fatty Acids, Omega-3; Humans; Male; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Muscular Disorders, Atrophic; Nutritional Status; Valerates | 2020 |
Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.
Topics: Animals; Cachexia; Dietary Supplements; Health; Humans; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Sarcopenia; Valerates; Wasting Syndrome | 2017 |
Beta-Hydroxy-Beta-Methyl Butyrate (HMB): From Experimental Data to Clinical Evidence in Sarcopenia.
Topics: Aged; Aged, 80 and over; Aging; Apoptosis; Cell Survival; Dietary Supplements; Frailty; Humans; Leucine; Middle Aged; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Sarcopenia; Valerates | 2018 |
Elderly persons with ICU-acquired weakness: the potential role for β-hydroxy-β-methylbutyrate (HMB) supplementation?
Topics: Aged; Aged, 80 and over; Aging; Critical Care; Dietary Supplements; Female; Humans; Intensive Care Units; Male; Muscle Strength; Muscle Weakness; Muscle, Skeletal; Muscular Atrophy; Quality of Life; Treatment Outcome; Valerates | 2014 |
Impact of supplementation with amino acids or their metabolites on muscle wasting in patients with critical illness or other muscle wasting illness: a systematic review.
Topics: Aged; Amino Acids; Amino Acids, Essential; Body Composition; Creatine; Critical Illness; Diet; Dietary Supplements; Enteral Nutrition; Female; Humans; Intensive Care Units; Leucine; Male; MEDLINE; Muscular Atrophy; Nutritional Status; Valerates | 2015 |
Efficacy of β-hydroxy-β-methylbutyrate supplementation in elderly and clinical populations.
Topics: Aged; Aging; Animals; Athletes; Dietary Supplements; Disease Models, Animal; Humans; Models, Biological; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Safety; Signal Transduction; Treatment Outcome; Valerates | 2013 |
3 trial(s) available for valerates and Muscular Atrophy
| Article | Year |
|---|---|
Beta-hydroxy-beta-methylbutyrate supplementation and functional outcomes in multitrauma patients: A pilot randomized controlled trial.
Topics: Dietary Supplements; Humans; Muscle, Skeletal; Muscular Atrophy; Pilot Projects; Valerates | 2023 |
Impact of β-hydroxy-β-methylbutyrate (HMB) on muscle loss and protein metabolism in critically ill patients: A RCT.
Topics: Aged; Amino Acids; Body Composition; Critical Illness; Dietary Supplements; Double-Blind Method; Electric Impedance; Enteral Nutrition; Female; Humans; Intensive Care Units; Male; Middle Aged; Muscle, Skeletal; Muscular Atrophy; Organ Dysfunction Scores; Prospective Studies; Quadriceps Muscle; Ultrasonography; Valerates | 2021 |
Effect of calcium β-hydroxy-β-methylbutyrate (CaHMB) with and without resistance training in men and women 65+yrs: a randomized, double-blind pilot trial.
Topics: Aged; Aging; Body Composition; Dietary Supplements; Double-Blind Method; Female; Hand Strength; Humans; Male; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Pilot Projects; Resistance Training; Valerates | 2013 |
13 other study(ies) available for valerates and Muscular Atrophy
| Article | Year |
|---|---|
Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.
Topics: Adult; Blood Coagulation; Body Mass Index; COVID-19; Cytokines; Extracellular Traps; Female; Hemoglobins; Humans; Male; Metabolome; Middle Aged; Muscular Atrophy; Neutrophils; Phenotype; Prognosis; SARS-CoV-2; Serum Albumin, Human; Severity of Illness Index; T-Lymphocytes; Valerates | 2021 |
Effects of the Combination of β-Hydroxy-β-Methyl Butyrate and R(+) Lipoic Acid in a Cellular Model of Sarcopenia.
Topics: Animals; Biomarkers; Cell Line; Cell Survival; Cells, Cultured; Dexamethasone; Fluorescent Antibody Technique; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Myoblasts; Oxidative Stress; Sarcopenia; Thioctic Acid; Valerates | 2020 |
Effects of β-hydroxy-β-methylbutyrate supplementation on muscle mass and strength in onabotulinumtoxin type-A-injected and contralateral quadriceps femoris in rabbits.
Topics: Animals; Botulinum Toxins, Type A; Dietary Supplements; Female; Humans; Muscle Strength; Muscle Weakness; Muscle, Skeletal; Muscular Atrophy; Quadriceps Muscle; Rabbits; Valerates | 2021 |
Inhibition of interleukin-6 decreases atrogene expression and ameliorates tail suspension-induced skeletal muscle atrophy.
Topics: Animals; Gene Expression Regulation; Hindlimb Suspension; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Muscular Atrophy; Valerates; Vitamin D | 2018 |
Beta-hydroxy beta-methyl butyrate decreases muscle protein degradation via increased Akt/FoxO3a signaling and mitochondrial biogenesis in weanling piglets after lipopolysaccharide challenge.
Topics: Animal Feed; Animals; Female; Forkhead Box Protein O3; Interleukin-1beta; Lipopolysaccharides; Male; Mitochondria; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Organelle Biogenesis; Proteolysis; Proto-Oncogene Proteins c-akt; Signal Transduction; Swine; Swine Diseases; Valerates | 2019 |
β-Hydroxy-β-methylbutyrate facilitates PI3K/Akt-dependent mammalian target of rapamycin and FoxO1/3a phosphorylations and alleviates tumor necrosis factor α/interferon γ-induced MuRF-1 expression in C2C12 cells.
Topics: Aging; Cell Line; Forkhead Box Protein O1; Forkhead Transcription Factors; Inflammation; Interferon-gamma; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Biosynthesis; Proteolysis; Proto-Oncogene Proteins c-akt; RNA, Messenger; TOR Serine-Threonine Kinases; Tripartite Motif Proteins; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases; Up-Regulation; Valerates | 2014 |
β-Hydroxy β-methylbutyrate improves dexamethasone-induced muscle atrophy by modulating the muscle degradation pathway in SD rat.
Topics: Animals; Creatine Kinase; Dexamethasone; Forkhead Transcription Factors; Glucocorticoids; Hand Strength; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Strength; Muscular Atrophy; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Signal Transduction; Tripartite Motif Proteins; Ubiquitin; Ubiquitin-Protein Ligases; Valerates | 2014 |
β-Hydroxy-β-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle.
Topics: Animals; Autophagy; Dexamethasone; Glucocorticoids; Lysosomes; Male; Muscle Fibers, Skeletal; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Phosphorylation; Proteasome Endopeptidase Complex; Proteolysis; Rats; Rats, Sprague-Dawley; Signal Transduction; Valerates | 2015 |
Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Topics: Angiotensin II; Animals; Caspase 3; Caspase 8; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; Enzyme Inhibitors; Imidazoles; Interferon-gamma; Metabolic Networks and Pathways; Mice; Models, Biological; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; p38 Mitogen-Activated Protein Kinases; Phenylalanine; Protein Processing, Post-Translational; Pyridines; Reactive Oxygen Species; Tumor Necrosis Factor-alpha; Valerates | 2008 |
Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Topics: Adaptor Proteins, Signal Transducing; Angiotensin II; Animals; Carrier Proteins; Cell Cycle Proteins; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; eIF-2 Kinase; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Eukaryotic Initiation Factors; Lipopolysaccharides; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; Phosphoproteins; Phosphorylation; Protein Biosynthesis; Tumor Necrosis Factors; Valerates | 2008 |
β-hydroxy-β-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia.
Topics: Animals; Body Weight; Cachexia; Down-Regulation; Drug Evaluation, Preclinical; Male; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Neoplasms, Experimental; Random Allocation; Rats; Rats, Wistar; Valerates; Weight Loss | 2011 |
β-Hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats.
Topics: Aging; Analysis of Variance; Animals; Apoptosis; bcl-2-Associated X Protein; Body Weight; Chi-Square Distribution; Crosses, Genetic; Disease Models, Animal; Hindlimb Suspension; In Situ Nick-End Labeling; Isometric Contraction; Male; Muscle Fibers, Skeletal; Muscle Strength; Muscle, Skeletal; Muscular Atrophy; Organ Size; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred BN; Rats, Inbred F344; Recovery of Function; Valerates | 2011 |
β-Hydroxy-β-methylbutyrate (HMB) prevents dexamethasone-induced myotube atrophy.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Dexamethasone; Muscle Fibers, Skeletal; Muscle Proteins; Muscle Weakness; Muscular Atrophy; Protein Biosynthesis; Proteolysis; Rats; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Valerates | 2012 |